# Neuroprotective Therapy and Therapeutic Target in Emergency Department

Study · id `cardio:ct-nct02143596` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02143596](<https://clinicaltrials.gov/study/NCT02143596>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02143596

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 159 participants.

## Technical summary

Registry record NCT02143596. Randomized; no masking; primary purpose treatment. Start 2010-11 (registry gives no type); primary completion 2013-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 159 participants (enrolled count; ClinicalTrials.gov record NCT02143596, source copy `cardio:ctgov-nct02143596-2014-05-26`, retrieved 2026-10-26)
- Start date: 2010-11 (registry gives no type) (ClinicalTrials.gov record NCT02143596, source copy `cardio:ctgov-nct02143596-2014-05-26`, retrieved 2026-10-26)
- Primary completion: 2013-12 (actual) (ClinicalTrials.gov record NCT02143596, source copy `cardio:ctgov-nct02143596-2014-05-26`, retrieved 2026-10-26)
- Completion: 2013-12 (actual) (ClinicalTrials.gov record NCT02143596, source copy `cardio:ctgov-nct02143596-2014-05-26`, retrieved 2026-10-26)
- Countries: Taiwan (ClinicalTrials.gov record NCT02143596, source copy `cardio:ctgov-nct02143596-2014-05-26`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02143596-2014-05-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: Neuroprotective Therapy and Therapeutic Target in Emergency Department
- Condition: Stroke
- Condition: Dehydration
- Intervention (Other): normal saline
- Lead sponsor: Chang Gung Memorial Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Chang Gung Memorial Hospital (`cardio:org-chang-gung-memorial-hospital`)

## Provenance

Content hash: 937c702347f128389b3aa31c27559412ab60ff223bafe2a8db48d4a202342c9b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
